CoChat
Cited by 234

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Metabolic pathways in obesity-related breast cancer

Open access
Brown, Kristy A. · 2021 · Nature Reviews Endocrinology

Abstract

This Review focuses on the mechanistic evidence for a link between obesity, dysregulated cellular metabolism and breast cancer. Strong evidence now links obesity with the development of 13 different types of cancer, including oestrogen receptor-positive breast cancer in postmenopausal women. A number of local and systemic changes are hypothesized to support this relationship, including increased circulating levels of insulin and glucose as well as adipose tissue-derived oestrogens, adipokines and inflammatory mediators. Metabolic pathways of energy production and utilization are dysregulated in tumour cells and this dysregulation is a newly accepted hallmark of cancer. Dysregulated metabolism is also hypothesized to be a feature of non-neoplastic cells in the tumour microenvironment. Obesity-associated factors regulate metabolic pathways in both breast cancer cells and cells in the breast microenvironment, which provides a molecular link between obesity and breast cancer. Consequently, interventions that target these pathways might provide a benefit in postmenopausal women and individuals with obesity, a population at high risk of breast cancer. Obesity is linked to dysregulated cellular energetics in neoplastic and non-neoplastic cells in the tumour microenvironment. Here, Brown discusses the interdependence of metabolic pathways of oestrogen production in breast tissue and the obesity-related mechanisms that promote breast cancer growth. Strong evidence links obesity to the development of 13 types of cancer, including oestrogen receptor-positive breast cancer in postmenopausal women. Metabolic pathways involving PI3K–AKT, HIF1α, LKB1–AMPK and p53 are key regulators of breast cancer cell metabolism and growth. Obesity-associated factors drive metabolic alterations in both breast cancer cells and cells of the breast microenvironment that support tumour growth. Therapies that target metabolic pathways might prove effective at treating and preventing breast cancer via effects on cancer cells, the tumour microenvironment and whole-body metabolism. Strong evidence links obesity to the development of 13 types of cancer, including oestrogen receptor-positive breast cancer in postmenopausal women. Metabolic pathways involving PI3K–AKT, HIF1α, LKB1–AMPK and p53 are key regulators of breast cancer cell metabolism and growth. Obesity-associated factors drive metabolic alterations in both breast cancer cells and cells of the breast microenvironment that support tumour growth. Therapies that target metabolic pathways might prove effective at treating and preventing breast cancer via effects on cancer cells, the tumour microenvironment and whole-body metabolism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41574-021-00487-0

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 234

Metadata

Authors
Brown, K. A.
Venue
Nature Reviews Endocrinology
Published
2021-04-29
Volume
17
Issue
6
Pages
350-363
ISSN
  • 1759-5029 (ISSN-L)
  • 1759-5037
OpenAlex
W3157893392
Cited by
234
References
32
FWCI
4.45
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic pathways in obesity-related breast cancer. https://app.cochat.ai/papers/10.1038/s41574-021-00487-0
The paper
Brown, K. A. (2021). Metabolic pathways in obesity-related breast cancer. Nature Reviews Endocrinology. https://doi.org/10.1038/s41574-021-00487-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.